Quest Diagnostics

Cognitive computing shakes up healthcare: What execs need to knowThe concepts that power cognitive computing and AI have grown to include substantial healthcare advancements.
Four solutions to value-based care challengesAn annual study commissioned by Quest Diagnostics and Inovalon reveals interesting findings to keep value-based care moving forward.
Researchers identify more effective, cost-efficient test for breast cancer riskNew findings reveal this genetic test to assess breast cancer risk could be more effective than others.
Seven ways health execs can prepare for the futureSeven ways health execs can prepare for the future.
Four priorities your health plan must embrace to thrive in the future
Four priorities your health plan must embrace to thrive in the futureHealth plans of the future will focus on consumers: designing products, care and services to support improved health.
New Products: Test launched to improve prostate biopsy decision processOther new products discussed in this article include a surgical training model, devices designed to improve prostate biopsy accuracy, an updated label and more.
3 ways pharmacists can combat Rx drug misuseA new analysis found that Americans are misusing drugs–both illicit and prescribed drugs– at an alarming rate.
Accelerate value-based care with these toolsA new Quest Diagnostics and Inovalon study cites barriers to value-based care, but offers advice on how to overcome them.
New diagnostic tests help physicians predict HCV drug resistanceHep C virus testing supports value of diagnostics in precision medicine.
First Zika test on marketThe first US test for the Zika virus is available after Quest Diagnostics received an Emergency Use Authorization (EUA) for its Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test).